Curis CRIS
NASDAQ CRIS
$0.83 0.00 (-0.54%)
As of: Oct 1, 2026 · 3:58 PM EDT

Curis (CRIS) Liabilities and Shareholders Equity (2010 - 2026)

Updated

Curis (CRIS) recorded Liabilities and Shareholders Equity of $18.97 million in Q2 2026, down 35.1% from $29.23 million a year earlier and down 36.1% from the prior quarter.

Analysis

Curis (CRIS) Liabilities and Shareholders Equity (2010 - 2026) Analysis & Trends

At the end of FY2025, Curis reported Liabilities and Shareholders Equity of $19.97 million, down 51.6% from FY2024.

  • Annual Liabilities and Shareholders Equity has declined for five straight years, with a five-year compound annual growth rate of -37.2% (FY2020 to FY2025).
  • Across earlier years, Liabilities and Shareholders Equity came in at $41.27 million in FY2024 (-46.6%), $77.28 million in FY2023 (-29.0%), $108.85 million in FY2022 (-32.9%) and $162.3 million in FY2021 (-20.6%).
  • The Q2 2026 figure is the lowest quarterly Liabilities and Shareholders Equity in data going back to Q4 2010.
  • On a year-over-year basis, Liabilities and Shareholders Equity has declined for 19 consecutive quarters, with an average decline of 40.5% over the last eight quarters.
  • Peak year-over-year performance for Liabilities and Shareholders Equity in the last five years was growth of 276.4% in Q3 2021, against a decline of 52.8% in Q3 2024 at the low end.
  • Per Business Quant, the preceding three quarters came in at $29.69 million (Q1 2026), $19.97 million (Q4 2025) and $27.64 million (Q3 2025).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Liabilities and Shareholders Equity (Qtr)
1 Johnson & Johnson 638.12 Bn 556.64 Bn 17.26 Bn 201.06 Bn
2 AbbVie 462.60 Bn 435.75 Bn 12.70 Bn 135.12 Bn
3 Merck 358.70 Bn 313.13 Bn 12.21 Bn 129.80 Bn
4 Novartis Ag 272.16 Bn 228.03 Bn 11.24 Bn 122.03 Bn
5 Astrazeneca 250.36 Bn 223.92 Bn 12.86 Bn 115.83 Bn
6 Amgen 227.87 Bn 183.27 Bn 7.24 Bn 95.64 Bn
7 Gilead Sciences 184.97 Bn 159.08 Bn 6.22 Bn 49.36 Bn
8 Pfizer 162.61 Bn 109.56 Bn 10.94 Bn 201.13 Bn
9 Vertex Pharmaceuticals 132.45 Bn 104.46 Bn 2.84 Bn 27.42 Bn
10 Curis 1.64 Mn -32.55 Mn - 18.97 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 18.97 Mn
Mar 31, 2026 29.69 Mn
Dec 31, 2025 19.97 Mn
Sep 30, 2025 27.64 Mn
Jun 30, 2025 29.23 Mn
Mar 31, 2025 39.33 Mn
Dec 31, 2024 41.27 Mn
Sep 30, 2024 42.47 Mn
Jun 30, 2024 50.41 Mn
Mar 31, 2024 62.02 Mn
Dec 31, 2023 77.28 Mn
Sep 30, 2023 89.98 Mn
Jun 30, 2023 84.31 Mn
Mar 31, 2023 94.54 Mn
Dec 31, 2022 108.85 Mn
Sep 30, 2022 122.85 Mn
Jun 30, 2022 128.83 Mn
Mar 31, 2022 140.74 Mn
Dec 31, 2021 162.30 Mn
Sep 30, 2021 172.09 Mn
API Access

Curis Liabilities and Shareholders Equity API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=liabilities-and-shareholders-equity&ticker=CRIS&period=max&api_key=YOUR_API_KEY